Market Cap 359.62M
Revenue (ttm) 36.56M
Net Income (ttm) -88.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -243.38%
Debt to Equity Ratio 0.00
Volume 795,500
Avg Vol 812,876
Day's Range N/A - N/A
Shares Out 54.08M
Stochastic %K 2%
Beta 0.99
Analysts Strong Sell
Price Target $23.88

Latest News on STOK

Stoke Therapeutics Stock Slips as CEO Steps Down

Mar 18, 2025, 12:56 PM EDT - 15 days ago

Stoke Therapeutics Stock Slips as CEO Steps Down


Stoke Therapeutics Announces CEO Transition

Mar 18, 2025, 6:58 AM EDT - 15 days ago

Stoke Therapeutics Announces CEO Transition


Stoke Therapeutics: A Pivotal Moment For This RNA Pioneer

Feb 16, 2025, 2:23 PM EST - 6 weeks ago

Stoke Therapeutics: A Pivotal Moment For This RNA Pioneer


Stoke Therapeutics: The First Gene Therapy For Dravet Syndrome

Sep 7, 2024, 4:03 AM EDT - 7 months ago

Stoke Therapeutics: The First Gene Therapy For Dravet Syndrome


Stoke Therapeutics Announces Proposed Public Offering

Mar 26, 2024, 4:07 PM EDT - 1 year ago

Stoke Therapeutics Announces Proposed Public Offering


Stoke Therapeutics Is Unable To Derisk Its Platform

Sep 10, 2023, 5:08 PM EDT - 1 year ago

Stoke Therapeutics Is Unable To Derisk Its Platform